PHENYTOIN vs VIGABATRIN

Compare PHENYTOIN (Phenytoin) and VIGABATRIN (VIGADRONE) — clinical data, side effects, and patient experiences.

PHENYTOIN

Phenytoin, Dilantin · Anticonvulsant

How it works

12.1 Mechanism of Action The precise mechanism by which phenytoin exerts its therapeutic effect has not been established but is thought to involve the voltage-dependent blockade of...

Approved for

1 INDICATIONS AND USAGE Phenytoin chewable tablets are indicated for the treatment of generalized tonic-clonic (grand mal) and complex partial (psychomotor

temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. ( 1 )

OralTablet

VIGABATRIN

VIGADRONE, Sabril · Anticonvulsant

How it works

12.1 Mechanism of Action The precise mechanism of vigabatrin's anti-seizure effect is unknown, but it is believed to be the result of its action as an irreversible inhibitor of γ-a...

Approved for

See full prescribing information

OralTablet

Quick Comparison

PHENYTOINVIGABATRIN

Drug Class

Anticonvulsant

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

PHENYTOIN

Drug Not Working

>10%

Falls

1-10%

Dizziness

1-10%

Headache

0.1-1%

Nausea

0.1-1%

Fatigue

0.1-1%

Fever

0.1-1%

Rash

0.1-1%

VIGABATRIN

Drug Not Working

>10%

Drowsiness

1-10%

Vomiting

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

PHENYTOIN

5 WARNINGS AND PRECAUTIONS • Withdrawal Precipitated Seizure: May precipitate status epilepticus
2 ) • Serious Dermatologic Reactions: Discontinue phenytoin chewable tablets at the first sign of a rash, unless the rash is clearly not drug-related
2 Suicidal Behavior and Ideation Antiepileptic drugs (AEDs), including phenytoin chewable tablets, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication
Pooled analyses of 199 placebo-controlled clinical trials (mono- and adjunctive therapy) of 11 different AEDs showed that patients randomized to one of the AEDs had approximately twice the risk (adjusted Relative Risk 1

VIGABATRIN

5 WARNINGS AND PRECAUTIONS Abnormal MRI signal changes and intramyelinic edema have been reported in some infants with Infantile Spasms receiving vigabatrin ( 5
4 ) Suicidal behavior and ideation: Antiepileptic drugs, including VIGADRONE, increase the risk of suicidal thoughts and behavior ( 5
Because of this risk and because, when it is effective, VIGADRONE provides an observable symptomatic benefit; patient response and continued need for treatment should be periodically assessed
For this reason, the understanding of the risk is primarily based on the adult experience

Clinical Trial Data

No head-to-head clinical studies found for PHENYTOIN vs VIGABATRIN.

PHENYTOIN vs VIGABATRIN: What You Should Know

Key Differences

Both PHENYTOIN and VIGABATRIN belong to the Anticonvulsant class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

PHENYTOIN carries 4 FDA warnings. VIGABATRIN carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

CLOBAZAM vs PHENYTOIN→LEVETIRACETAM vs PHENYTOIN→LAMOTRIGINE vs PHENYTOIN→PHENYTOIN vs TOPIRAMATE→CARBAMAZEPINE vs PHENYTOIN→OXCARBAZEPINE vs PHENYTOIN→

Loading comparison data...

PHENYTOIN vs VIGABATRIN

Compare PHENYTOIN (Phenytoin) and VIGABATRIN (VIGADRONE) — clinical data, side effects, and patient experiences.

PHENYTOIN

Phenytoin, Dilantin · Anticonvulsant

How it works

12.1 Mechanism of Action The precise mechanism by which phenytoin exerts its therapeutic effect has not been established but is thought to involve the voltage-dependent blockade of...

Approved for

1 INDICATIONS AND USAGE Phenytoin chewable tablets are indicated for the treatment of generalized tonic-clonic (grand mal) and complex partial (psychomotor

temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. ( 1 )

OralTablet

VIGABATRIN

VIGADRONE, Sabril · Anticonvulsant

How it works

12.1 Mechanism of Action The precise mechanism of vigabatrin's anti-seizure effect is unknown, but it is believed to be the result of its action as an irreversible inhibitor of γ-a...

Approved for

See full prescribing information

OralTablet

Quick Comparison

PHENYTOINVIGABATRIN

Drug Class

Anticonvulsant

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

PHENYTOIN

Drug Not Working

>10%

Falls

1-10%

Dizziness

1-10%

Headache

0.1-1%

Nausea

0.1-1%

Fatigue

0.1-1%

Fever

0.1-1%

Rash

0.1-1%

VIGABATRIN

Drug Not Working

>10%

Drowsiness

1-10%

Vomiting

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

PHENYTOIN

5 WARNINGS AND PRECAUTIONS • Withdrawal Precipitated Seizure: May precipitate status epilepticus
2 ) • Serious Dermatologic Reactions: Discontinue phenytoin chewable tablets at the first sign of a rash, unless the rash is clearly not drug-related
2 Suicidal Behavior and Ideation Antiepileptic drugs (AEDs), including phenytoin chewable tablets, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication
Pooled analyses of 199 placebo-controlled clinical trials (mono- and adjunctive therapy) of 11 different AEDs showed that patients randomized to one of the AEDs had approximately twice the risk (adjusted Relative Risk 1

VIGABATRIN

5 WARNINGS AND PRECAUTIONS Abnormal MRI signal changes and intramyelinic edema have been reported in some infants with Infantile Spasms receiving vigabatrin ( 5
4 ) Suicidal behavior and ideation: Antiepileptic drugs, including VIGADRONE, increase the risk of suicidal thoughts and behavior ( 5
Because of this risk and because, when it is effective, VIGADRONE provides an observable symptomatic benefit; patient response and continued need for treatment should be periodically assessed
For this reason, the understanding of the risk is primarily based on the adult experience

Clinical Trial Data

No head-to-head clinical studies found for PHENYTOIN vs VIGABATRIN.

PHENYTOIN vs VIGABATRIN: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.